Literature DB >> 18480028

Identification of putative active site residues of ACAT enzymes.

Akash Das1, Matthew A Davis, Lawrence L Rudel.   

Abstract

In this report, we sought to determine the putative active site residues of ACAT enzymes. For experimental purposes, a particular region of the C-terminal end of the ACAT protein was selected as the putative active site domain due to its high degree of sequence conservation from yeast to humans. Because ACAT enzymes have an intrinsic thioesterase activity, we hypothesized that by analogy with the thioesterase domain of fatty acid synthase, the active site of ACAT enzymes may comprise a catalytic triad of ser-his-asp (S-H-D) amino acid residues. Mutagenesis studies revealed that in ACAT1, S456, H460, and D400 were essential for activity. In ACAT2, H438 was required for enzymatic activity. However, mutation of D378 destabilized the enzyme. Surprisingly, we were unable to identify any S mutations of ACAT2 that abolished catalytic activity. Moreover, ACAT2 was insensitive to serine-modifying reagents, whereas ACAT1 was not. Further studies indicated that tyrosine residues may be important for ACAT activity. Mutational analysis showed that the tyrosine residue of the highly conserved FYXDWWN motif was important for ACAT activity. Furthermore, Y518 was necessary for ACAT1 activity, whereas the analogous residue in ACAT2, Y496, was not. The available data suggest that the amino acid requirement for ACAT activity may be different for the two ACAT isozymes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480028      PMCID: PMC2444009          DOI: 10.1194/jlr.M800131-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  37 in total

1.  Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice.

Authors:  K K Buhman; M Accad; S Novak; R S Choi; J S Wong; R L Hamilton; S Turley; R V Farese
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

Review 2.  Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) Inhibitors as hypolipidemic and antiatherosclerosis drugs.

Authors:  Carlos Leon; John S Hill; Kishor M Wasan
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

Review 3.  ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia.

Authors:  Lawrence L Rudel; Richard G Lee; Paolo Parini
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-14       Impact factor: 8.311

Review 4.  Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis.

Authors:  L L Rudel; R G Lee; T L Cockman
Journal:  Curr Opin Lipidol       Date:  2001-04       Impact factor: 4.776

5.  A proposed architecture for lecithin cholesterol acyl transferase (LCAT): identification of the catalytic triad and molecular modeling.

Authors:  F Peelman; N Vinaimont; A Verhee; B Vanloo; J L Verschelde; C Labeur; S Seguret-Mace; N Duverger; G Hutchinson; J Vandekerckhove; J Tavernier; M Rosseneu
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

6.  Complementation of mutation in acyl-CoA:cholesterol acyltransferase (ACAT) fails to restore sterol regulation in ACAT-defective sterol-resistant hamster cells.

Authors:  G Cao; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1996-06-14       Impact factor: 5.157

7.  Role of acyl-coenzyme A:cholesterol acyltransferase-1 in the control of hepatic very low density lipoprotein secretion and low density lipoprotein receptor expression in the mouse and hamster.

Authors:  D K Spady; M N Willard; R S Meidell
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

8.  Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Emily L Willner; Bryan Tow; Kimberly K Buhman; Martha Wilson; David A Sanan; Lawrence L Rudel; Robert V Farese
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

9.  Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages.

Authors:  S Fazio; A S Major; L L Swift; L A Gleaves; M Accad; M F Linton; R V Farese
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

10.  Chemical modification of acyl-CoA:cholesterol O-acyltransferase. 1. Identification of acyl-CoA:cholesterol O-acyltransferase subtypes by differential diethyl pyrocarbonate sensitivity.

Authors:  P M Kinnunen; A DeMichele; L G Lange
Journal:  Biochemistry       Date:  1988-09-20       Impact factor: 3.162

View more
  14 in total

1.  Fatty acylation of Wnt proteins.

Authors:  Aaron H Nile; Rami N Hannoush
Journal:  Nat Chem Biol       Date:  2016-02       Impact factor: 15.040

2.  Topological orientation of acyl-CoA:diacylglycerol acyltransferase-1 (DGAT1) and identification of a putative active site histidine and the role of the n terminus in dimer/tetramer formation.

Authors:  Pamela J McFie; Sandra L Stone; Shanna L Banman; Scot J Stone
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

3.  A robust all-atom model for LCAT generated by homology modeling.

Authors:  Jere P Segrest; Martin K Jones; Andrea Catte; Saravana P Thirumuruganandham
Journal:  J Lipid Res       Date:  2015-01-14       Impact factor: 5.922

4.  Structural basis for catalysis and substrate specificity of human ACAT1.

Authors:  Hongwu Qian; Xin Zhao; Renhong Yan; Xia Yao; Shuai Gao; Xue Sun; Ximing Du; Hongyuan Yang; Catherine C L Wong; Nieng Yan
Journal:  Nature       Date:  2020-05-13       Impact factor: 49.962

Review 5.  ACAT inhibition and amyloid beta reduction.

Authors:  Raja Bhattacharyya; Dora M Kovacs
Journal:  Biochim Biophys Acta       Date:  2010-04-14

6.  Identification of key residues and regions important for porcupine-mediated Wnt acylation.

Authors:  Jessica Rios-Esteves; Brittany Haugen; Marilyn D Resh
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

Review 7.  How lipid droplets "TAG" along: Glycerolipid synthetic enzymes and lipid storage.

Authors:  Huan Wang; Michael V Airola; Karen Reue
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-06-20       Impact factor: 4.698

8.  Saccharomyces cerevisiae lysophospholipid acyltransferase, Lpt1, requires Asp146 and Glu297 for catalysis.

Authors:  Paul Renauer; Nour Nasiri; Peter Oelkers
Journal:  J Lipid Res       Date:  2015-09-17       Impact factor: 5.922

Review 9.  Acyl-coenzyme A:cholesterol acyltransferases.

Authors:  Ta-Yuan Chang; Bo-Liang Li; Catherine C Y Chang; Yasuomi Urano
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-13       Impact factor: 4.310

10.  Cholesterol and fatty acids regulate cysteine ubiquitylation of ACAT2 through competitive oxidation.

Authors:  Yong-Jian Wang; Yan Bian; Jie Luo; Ming Lu; Ying Xiong; Shu-Yuan Guo; Hui-Yong Yin; Xu Lin; Qin Li; Catherine C Y Chang; Ta-Yuan Chang; Bo-Liang Li; Bao-Liang Song
Journal:  Nat Cell Biol       Date:  2017-06-12       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.